The role of GABAA receptors in mediating the effects of alcohol in the central nervous system

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 4, 2003, Pages 263-274

  Davies, Martin ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Alcohol drinking; Alcohol induced disorders; Alcoholism; Ethanol; Fetal alcohol syndrome; GABA agonists; GABA A; Gamma aminobutyric acid; Genetic predisposition to disease; Ion channel gating; Receptors

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ACAMPROSATE; ALCOHOL; ALDEHYDE DEHYDROGENASE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICUCULLINE; DISULFIRAM; FLUMAZENIL; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; NALTREXONE; PICROTOXIN;

ALCOHOL METABOLISM; ALCOHOLISM; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; EVIDENCE BASED MEDICINE; GENETIC ANALYSIS; HUMAN; HYPERVENTILATION; NAUSEA; PANIC; REVIEW; TACHYCARDIA; VOMITING; ANIMAL; BRAIN; CELL MEMBRANE; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; FETAL ALCOHOL SYNDROME; GENETICS; METABOLISM; PREGNANCY;

ALCOHOLISM; ANIMALS; BRAIN; CELL MEMBRANE; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; PREGNANCY; RECEPTORS, GABA-A; SELF ADMINISTRATION;

EID: 0141829702     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Holden C. Alcoholism and the medical cost crunch. Science 1987;235:1132-3.
2. Marshall EJ, Edwards G, Taylor C. Mortality in men with drinking problems: a 20-year follow up. Addiction 1994;89:1293-8.
3. Lipson T. The fetal alcohol syndrome in Australia. Med J Aust 1994;161(8):461-2.
4. Loney EA, Habbick BF, Nanson JL. Hospital utilization of Saskatchewan people with fetal alcohol syndrome. Can J Public Health 1998;89(5):333-6.
5. Tanaka H. Fetal alcohol syndrome: a Japanese perspective. Ann Med 1998;30(1):21-6.
6. Warren KR, Calhoun FJ, May PA, Viljoen DL, Li TK, Tanaka H, et al. Fetal alcohol syndrome: an international perspective. Alcohol Clin Exp Res 2001;25(5 Suppl):202S-206S.
7. Williams RJ, Odaibo FS, McGee JM. Incidence of fetal alcohol syndrome in northeastern Manitoba. Can J Public Health 1999;90(3):192-4.
8. Olson HC, Morse BA, Huffine C. Development and psychopathology: fetal alcohol syndrome and related conditions. Semin Clin Neuropsychiatry 1998;3(4):262-84.
9. Stromland K. Present state of the fetal alcohol syndrome. Acta Ophthalmol Scand Suppl 1996;(219):10-2.
10. Sellers EM, Busto U, Benzodiazepines and ethanol: assessment of the effects and consequences of psychotropic drug interactions. J Clin Psychopharmacol 1982;2(4):249-62.
11. Ciraulo DA, Barnhill J. Pharmacokinetic mechanisms of ethanol-psychotropic drug interactions. NIDA Res Monogr 1986;68:73-88.
12. Poikolainen K. Estimated lethal ethanol concentrations in relation to age, aspiration, and drugs. Alcohol Clin Exp Res 1984;8(2):223-5.
13. Katzung BG. Basic and clinical pharmacology. 8th ed. Toronto: Lange Medical Books/McGraw-Hill; 2001.
14. Grilly DM. Drugs and human behavior. 4th ed. Toronto: Allyn and Bacon; 2002.
15. Harris RA. Ethanol actions on multiple ion channels: which are important? Alcohol Clin Exp Res 1999; 23:1563-70.
16. Tabakoff B, Hoffman P. Alcohol addiction: an enigma among us. Neuron 1996;16:909-12.
17. Chandler LJ, Harris RA, Crews FT. Ethanol tolerance and synaptic plasticity. Trends Pharmacol Sci 1998;19(12):491-5.
18. Littleton J, Little H. Current concepts of ethanol dependence. Addiction 1994;89(11):1397-412.
19. Macdonald RL. Ethanol, γ-aminobutyrate type A receptors, and protein kinase C phosphorylation. Proc Natl Acad Sci U S A 1995;92:3633-5.
20. Pandey SC. Neuronal signaling systems and ethanol dependence. Mol Neurobiol 1998;17(1-3):1-15.
21. Narahashi T, Kuriyama K, Illes P, Wirkner K, Fischer W, Muhlberg K, et al. Neuroreceptors and ion channels as targets of alcohol. Alcohol Clin Exp Res 2001;25(5 Suppl):182S-188S.
22. Valenzuela CF, Cardoso RA, Wick MJ, Weiner JL, Dunwiddie TV, Harris RA. Effects of ethanol on recombinant glycine receptors expressed in mammalian cell lines. Alcohol Clin Exp Res 1998;22(5):1132-6.
23. Cardoso RA, Brozowski SJ, Chavez-Noriega LE, Harpold M, Valenzuela CF, Harris RA. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes, J Pharmacol Exp Ther 1999;289(2):774-80.
24. 3 receptors and the neural actions of alcohols: an increasingly exciting topic. Neurochem Int 1999;35(2):125-30.
25. A and glycine receptor function. Neurochem Int 1999;35(2):115-23.
26. Hoffman PL, Rabe CS, Moses F, Tabakoff B. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 1989;52(6):1937-40.
27. Widmer H, Lemos JR, Treistman SN. Ethanol reduces the duration of single evoked spikes by a selective inhibition of voltage-gated calcium currents in acutely dissociated supraoptic neurons of the rat. J Neuroendocrinol 1998;10(6):399-406.
28. 2+ channel in neurohypophysial terminals. J Neurosci 1994;14(9):5453-60.
29. Anton RF. Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry 2001;62(Suppl 20):11-7.
30. Spanagel R, Zieglgansberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997;18(2):54-9.
31. Lipsky JJ, Shen ML, Naylor S. Overview - in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem Biol Interact 2001;130-2(1-3):81-91.
32. Lipsky JJ, Shen ML, Naylor S. In vivo inhibition of aldehyde dehydrogenase by disulfiram. Chem Biol Interact 2001;130-2(1-3):93-102.
33. Wright C, Moore RD. Disulfiram treatment of alcoholism. Am J Med 1990;88(6):647-55.
34. Gianoulakis C. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Alcohol Alcohol 1996;31(Suppl 1):33-42.
35. O'Malley SS. Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Alcohol Alcohol 1996;31(Suppl 1):77-81.
36. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49(11):876-80.
37. Wilde MI, Wagstaff AJ. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 1997;53(6):1038-53.
38. B receptors in nucleus accumbens neurons. Alcohol Clin Exp Res 1998;22(1):183-91.
39. 2+ channels in cultured rat mesencephalic neurones, Naunyn Schmiedebergs Arch Pharmacol 2000;362(4-5):440-3.
40. Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M. Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology (Berl) 2002;160(4):408-13.
41. Yost DA. Alcohol withdrawal syndrome. Am Fam Physician 1996;54(2):657-64, 669.
42. Morris JC, Victor M. Alcohol withdrawal seizures. Emerg Med Clin North Am 1987;5(4):827-39.
43. A receptors in the acute and chronic effects of ethanol. Psychopharmacology (Berl) 1998;139(1-2):2-19.
44. A receptor subtypes. Pharmacol Rev 1995;47(2):181-234.
45. - channel complex using monoclonal antibodies in the dorsal lateral geniculate nucleus of the cat. Eur J Neurosci 1990;2(5):414-29.
46. A receptor determined by electron microscopic image analysis. J Neurochem 1994;62(2):815-8.
47. A receptor subunit types and their expression. Adv Biochem Psychopharmacol 1992;47:17-27.
48. Bonnert TP, McKernan RM, Farrar S, le Bourdelles B, Heavens RP, Smith DW, et al. θ, a novel γ-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci U S A 1999;96(17):9891-6.
49. A receptor subtypes. Pharmacol Rev 1995;47(2):181-234.
50. Hadingham KL, Wingrove PB, Wafford KA, Bain C, Kemp JA, Palmer KJ, et al. Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors. Mol Pharmacol 1993;44(6):1211-8.
51. A receptor: Domains implicated by mutational analysis. Front Biosci 1996;1:d214-d233.
52. A-receptor subtypes really occur in the brain? Trends Neurosci 1996;19(4):139-43.
53. Whiting PJ, Bonnert TP, McKernan RM, Farrar S, le Bourdelles B, Heavens RP, et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 1999;868:645-53.
54. A receptors. Trends Pharmacol Sci 1997;18(11):425-9.
55. Changeux JP, Edelstein SJ. Allosteric receptors after 30 years. Neuron 1998;21:959-80.
56. A receptors. Trends Pharmacol Sci 1995;16(5):162-8.
57. Olsen RW. Drug interactions at the GABA receptor-ionophore complex. Ann Rev Pharmacol Toxicol 1982;22:245-77.
58. - ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 1992;13(12):446-50.
59. Doble A, Martin ILM. Multiple benzodiazepine receptors: No reason for anxiety. Trends Pharmacol Sci 1992;13:76-81.
60. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998;50(2):291-313.
61. A receptor form ion channels with properties of the native receptor. Science 1988;242(4878):577-9.
62. - ion flux in vitro: possible relationship to the anxiolytic and intoxicating actions of alcohol. Psychopharmacol Bull 1987;23(3):445-51.
63. Marszalec W, Kurata Y, Hamilton BJ, Carter DB, Narahashi T. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells. J Pharmacol Exp Ther 1994;269(1):157-63.
64. Siggins GR, Pittman QJ, French ED. Effects of ethanol on CA1 and CA3 pyramidal cells in the hippocampal slice preparation: an intracellular study. Brain Res 1987;414:22-34.
65. A-activated currents in adult medial septum/diagonal band neurons. Brain Res 1994;635(1-2):283-92.
66. A receptors requires phosphorylation of the alternatively spliced variant of the gamma 2 subunit. FEBS Lett 1992;313(2):113-7.
67. A receptor γ2L subunit in rat sensory neurons may not be necessary for ethanol sensitivity. Brain Res 1998;805(1-2):116-22.
68. A receptor-mediated currents: lack of subunit specificity. Eur J Pharmacol 1994;268(2):209-14.
69. A receptors are a target for alcohol. Nat Neurosci 2002;5(8):721-2.
70. Roth SH. Physical mechanisms of anesthesia. Annu Rev Pharmacol Toxicol 1979;19:159-78.
71. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev 1972;24(4):583-655.
72. Janoff AS, Pringle MJ, Miller KW. Correlation of general anesthetic potency with solubility in membranes. Biochim Biophys Acta 1981;649(1):125-8.
73. Pringle MJ, Brown KB, Miller KW. Can the lipid theories of anesthesia account for the cutoff in anesthetic potency in homologous series of alcohols? Mol Pharmacol 1981;19(1):49-55.
74. Franks NP, Lieb WR. Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects. Nature 1985;316(6026):349-51.
75. Franks NP, Lieb WR. Partitioning of long-chain alcohols into lipid bilayers: implications for mechanisms of general anesthesia. Proc Natl Acad Sci U S A 1986;83(14):5116-20.
76. Harris BD, Moody EJ, Basile AS, Skolnick P. Volatile anesthetics bidirectionally and stereospecifically modulate ligand binding to GABA receptors. Eur J Pharmacol 1994;267(3):269-74.
77. Franks NP, Lieb WR. Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science 1991;254(5030):427-30.
78. - influx. Eur J Pharmacol 1989;160(3):359-67.
79. A and glutamate receptors: relation to in vivo effects. Br J Pharmacol 1996;118(2):378-84.
80. - current by a series of n-alcohols disappears at a cutoff point of a longer-chain n-alcohol in rat dorsal root ganglion neurons. Neurosci Lett 1996;205(2):127-30.
81. Godden EL, Harris RA, Dunwiddie TV. Correlation between molecular volume and effects of n-alcohols on human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 2001;296(3):716-22.
82. Akinshola BE. Straight-chain alcohols exhibit a cutoff in potency for the inhibition of recombinant glutamate receptor subunits. Br J Pharmacol 2001;133(5):651-8.
83. Peoples RW, Ren H. Inhibition of N-methyl-D-aspartate receptors by straight-chain diols: implications for the mechanism of the alcohol cutoff effect. Mol Pharmacol 2002;61(1):169-76.
84. A receptor-channel kinetics. Neuroreport 1998;9:1769-75.
85. A and glycine receptors. Nature 1997;389:385-9.
86. Ye Q, Koltchine W, Mihic SJ, Mascia MP, Wick MJ, Finn SE, et al. Enhancement of glycine receptor function by ethanol is inversely correlated with molecular volume at position alpha267. J Biol Chem 1998;273(6):3314-9.
87. A receptor modulation of the rewarding and aversive effects of ethanol. Alcohol 2002;26(3):131-43.
88. Boyle AE, Segal R, Smith BR, Amit Z. Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol Biochem Behav 1993;46(1):179-82.
89. Petry NM. Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Exp Clin Psychopharmacol 1997;5(3):183-94.
90. Rassnick S, D'Amico E, Riley E, Koob GF. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcohol Clin Exp Res 1993;17(1):124-30.
91. Balakleevsky A, Colombo G, Fadda F, Gessa GL. Ro 19-4603, a benzodiazepine receptor inverse agonist, attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference. Alcohol Alcohol 1990;25(5):449-52.
92. Wegelius K, Honkanen A, Korpi ER. Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats. Eur J Pharmacol 1994;263(1-2):141-7.
93. Shelton KL, Balster RL. Effects of gamma-aminobutyric acid agonists and N-methyl-D-aspartate antagonists on a multiple schedule of ethanol and saccharin self-administration in rats. J Pharmacol Exp Ther 1997;280(3):1250-60.
94. Rimondini R, Sommer W, Heilig M. Effects of tiagabine and diazepam on operant ethanol self-administration in the rat. J Stud Alcohol 2002;63(1):100-6.
95. Kalivas PW, Duffy P, Eberhardt H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. j Pharmacol Exp Ther 1990;253(2):858-66.
96. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X, et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 1995;21(4):289-98.
97. A receptors containing α5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry. J Neurosci 2001;21(6):2166-77.
98. Kokka N, Sapp DW, Taylor AM, Olsen RW. The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol. Alcohol Clin Exp Res 1993;17(3):525-31.
99. A receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatment. Brain Res 1996;709(2):221-8.
100. A receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment. Alcohol Clin Exp Res 1998;22(9):2165-73.
101. A receptor-operated chloride channels. II. Chronic effects of ethanol. J Pharmacol Exp Ther 1990;253(2):713-9.
102. Devaud LL, Purdy RH, Morrow AL. The neurosteroid, 3 α-hydroxy-5 α-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res 1995;19(2):350-5.
103. A receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis. Mol Pharmacol 1995;48(5):861-8.
104. A receptor subunit peptide levles in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 1997;69:126-30.
105. A receptor gene expression in rat cortex: differential effects of two chronic diazepam treatment regimes. J Neurosci Res 2001;64(6):617-25.
106. A receptor α4 subunit in association with increased anxiety. J Neurosci 1998;18(14):5275-84.
107. Walter HJ, McMahon T, Dadgar J, Wang D, Messing RO. Ethanol regulates calcium channel subunits by protein kinase C delta-dependent and -independent mechanisms. J Biol Chem 2000;275(33):25717-22.
108. A receptors in rat hippocampal CA 1 pyramidal neurons. J Neurochem 1997;68(5):1949-59.
109. A receptor modulators and alcohol in mice lacking PKCε. Nature Neurosci 1999;2(11):997-1002.
110. Harris RA, McQuilkin SJ, Paylor R, Abeliovich A, Tonegawa S, Wehner JM. Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc Natl Acad Sci U S A 1995;92(9):3658-62.
111. Freund RK, Palmer MR. Beta adrenergic sensitization of γ-aminobutyric acid receptors to ethanol involves a cyclic AMP/protein kinase A second-messenger system. J Pharmacol Exp Ther 1997;254:1192-200.
112. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X, et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 1995;21(4):289-98.
113. Dohrman DP, Diamond I, Gordon AS. Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. Proc Natl Acad Sci U S A 1996;93(19):10217-21.
114. Gordon AS, Yao L, Dohrman DP, Diamond I. Ethanol alters the subcellular localization of cAMP-dependent protein kinase and protein kinase C. Alcohol Clin Exp Res 1998;22(5 Suppl):238S-242S.
115. Thiele TE, Willis B, Stadler J, Reynolds JG, Bernstein IL, McKnight GS. High ethanol consupmtion and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. J Neurosci 2000;20(10):RC75.
116. Homanics GE, Harrison NL, Quinlan JJ, Krasowski MD, Rick CE, De Blas AL, et al. Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of the gamma-aminobutyrate type A receptor. Neuropharmacol 1999;38(2):253-65.
117. Homanics GE, Ferguson C, Quinlan JJ, Daggett J, Snyder K, Lagenaur C, et al. Gene knockout of the α6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol 1997;51(4):588-96.
118. Mihalek RM, Bowers BJ, Wehner JM, Kralic JE, VanDoren MJ, Morrow AL, et al. GABA-A receptor δ subunit knockout mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res 2001;12:1708-18.
119. A receptor in rat thalamus. Mol Pharmacol 1999;56(1):110-5.
120. Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM. A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986;234(4781):1243-7.
121. Mulla Hummadi YM, Najim RA, Farjou IB. Benzodiazepines protect against ethanol-induced gastric mucosal damage in vitro. Fundam Clin Pharmacol 2001;15(4):247-54.
122. June HL, Devaraju SL, Eggers MW, Williams JA, Cason CR, Greene TL, et al. Benzodiazepine receptor antagonists modulate the actions of ethanol in alcohol-preferring and -nonpreferring rats. Eur J Pharmacol 1998; 342(2-3):139-51.
123. June HL, Zuccarelli D, Torres L, Craig KS, DeLong J, Allen A, et al. High-affinity benzodiazepine antagonists reduce responding maintained by ethanol presentation in ethanol-preferring rats. J Pharmacol Exp Ther 1998;284(3):1006-14.
124. Chan AW, Leong FW, Schanley DL, Langan MC, Penetrante F. Flumazenil (Ro15-1788) does not affect ethanol tolerance and dependence. Pharmacol Biochem Behav 1991;39(3):659-63.
125. Buck KJ, Heim H, Harris RA. Reversal of alcohol dependence and tolerance by a single administration of flumazenil. J Pharmacol Exp Ther 1991;257(3):984-9.
126. Masur J, Silva-Filho AR, de Souza ML, Pires ML. Lack of effect of the benzodiazepine receptor antagonist Ro 15-1788 on ethanol-induced intoxication in mice. Alcohol 1987;4(6):425-7.
127. Klotz U, Ziegler G, Rosenkranz B, Mikus G. Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol? Br J Clin Pharmacol 1986;22(5):513-20.
128. Nutt DGP, Wilson S, Groves S, Coupland N, Bailey J. Flumazenil in alcohol withdrawal. Alcohol Alcohol Suppl 1993;2:337-41.
129. Weerts EM, Tornatzky W, Miczek KA. Prevention of the proaggressive effects of alcohol in rats and squirrel monkeys by benzodiazepine receptor antagonists. Psychopharmacology (Berl) 1993;111(2):144-52.
130. Mendelson WB. The sleep-inducing effect of ethanol microinjection into the medial preoptic area is blocked by flumazenil. Brain Res 2001;892(1):118-21.
131. Koechling UM, Smith BR, Amit Z. Effects of GABA antagonists and habituation to novelty on ethanol-induced locomotor activity in mice. Alcohol Alcohol 1991;26(3):315-22.
132. Hellevuo K, Kiianmaa K, Korpi ER. Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol. Pharmacol Biochem Behav 1989;34(2):399-404.
133. A receptors modulate ethanol-induced conditioned place preference and taste aversion in mice. Psychopharmacology (Berl) 1999;144(4):363-72.
134. Radel M, Goldman D. Pharmacogenetics of alcohol response and alcoholism: the interplay of genes and environmental factors in thresholds for alcoholism. Drug Metab Dispos 2001;29(4 Pt 2):489-94.
135. Li TK. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking. J Stud Alcohol 2000;61(1):5-12.
136. Thomasson HR, Crabb DW, Edenberg HJ, Li TK, Hwu HG, Chen CC, et al. Low frequency of the ADH2*2 allele among Atayal natives of Taiwan with alcohol use disorders. Alcohol Clin Exp Res 1994;18(3):640-3.
137. Thomasson HR, Edenberg HJ, Crabb DW, Mai XL, Jerome RE, Li TK, et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 1991;48(4):677-81.
138. A receptors expressed in Xenopus oocytes. Science 1990;249(4966):291-3.
139. A receptor. Nature 1993;361(6410):356-9.
140. A receptors is essential for benzodiazepine agonist binding. J Biol Chem 1992;267(3):1426-9.
141. A receptor reveals the importance of residue 101 in determining the allosteric effects of benzodiazepine site ligands. Mol Pharmacol 1999;56(4):768-74.
142. Buck KJ, Finn DA. Genetic factors in addiction: QTL mapping and candidate gene studies implicate GABAergic genes in alcohol and barbiturate withdrawal in mice. Addiction 2001;96(1):139-49.
143. A receptor γ2 subunit variant with severity of acute physiological dependence on alcohol. Mamm Genome 1998;9(12):975-8.
144. A receptor γ2 subunit is associated with genetic susceptibility to ethanol-induced motor incoordination and hypothermia, conditioned taste aversion, and withdrawal in BXD/Ty recombinant inbred mice. Alcohol Clin Exp Res 2000;24(9):1327-34.
145. Buck K, Metten P, Belknap J, Crabbe J. Quantitative trait loci affecting risk for pentobarbital withdrawal map near alcohol withdrawal loci on mouse chromosomes 1, 4, and 11. Mamm Genome 1999;10(5):431-7.
146. Crabbe JC, Belknap JK, Mitchell SR, Crawshaw LI. Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice. J Pharmacol Exp Ther 1994;269(1):184-92.
147. Crabbe JC, Buck KJ, Metten P, Belknap JK. Strategies for identifying genes underlying drug abuse susceptibility. NIDA Res Monogr 1996;161:201-19.
148. 2C and GABA α6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biol Psychiatry 1999;45(5):647-51.
149. A α6 Pro385Ser substitution and benzodiazepine sensitivity. Am J Psychiatry 1999;156(9):1447-9.
150. Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL, et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998;55(11):989-94.
151. Larkby C, Day N. The effects of prenatal alcohol exposure. Alcohol Health Res World 1997;21:192-8.
152. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3(1):79-83.
153. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287(5455):1056-60.
154. Olney JW, Wozniak DF, Farber NB, Jevtovic-Todorovic V, Bittigau P, Ikonomidou C. The enigma of fetal alcohol neurotoxicity. Ann Med 2002;34(2):109-19.
155. Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U, et al. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol 2001;62(4):401-5.
156. - channels in cultured proliferating rat neuroepithelial cells. Neuroscience 2001;104(3):913-22.